Molt-4(人急性淋巴母细胞白血病细胞)
CBP60525
询 价
索取STR
产品描述
产品数据库
I. General information | |
Synonyms: | Molt-4 |
Background: | MOLT-4 was derived from the same patient as the MOLT-3 cell line (ATCC CRL-1552). The line was established from cells taken from a patient in relapse. |
Species: | Homo sapiens, human |
Tissue: | Blood |
Disease: | acute lymphoblastic leukemia |
Gender: | male,19 years |
Morphology: | lymphoblast |
Growth Mode: | suspension |
DNA Profile: | Amelogenin: XY CSF1PO: 11, 12, 13 D13S317: 12, 13 D16S539: 11, 14 D5S818: 12 D7S820: 8, 10, 11 THO1: 6, 8 TPOX: 8 vWA: 17, 18 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI1640+10%FBS Molt-4完全培养基,# CBP60525M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | CD1 (49%), CD2 (35%), CD3 A (26%) B (33%) C (34%), CD4 (55%), CD5 (72%), CD6 (22%), CD7 (77%) |
Genes Expressed: | high levels of terminal deoxynucleotidyl transferase (TdT) are produced. |
Cellular Products: | high levels of terminal deoxynucleotidyl transferase (TdT) are produced |
Tumor Formation: | Yes, in untreated nude mice, anti lymphocyte serum treated mice and X-irradiated mice,Ref |
Comments: | The patient had received prior multidrug chemotherapy. There is a G -> A mutation at codon 248 of the p53 gene. P53 is not expressed. The cells do not produce immunoglobulin or Epstein-Barr virus. The line was originally contaminated with mycoplasma but has been cured with antibiotics. For more information, please contact Cobioer (4008-750-250). |